| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 24 | 2025 | 560 | 3.050 |
Why?
|
| Intellectual Disability | 33 | 2024 | 1087 | 3.000 |
Why?
|
| Phenotype | 67 | 2025 | 4529 | 2.950 |
Why?
|
| Genetic Diseases, Inborn | 11 | 2024 | 456 | 1.930 |
Why?
|
| Genomics | 15 | 2025 | 1647 | 1.860 |
Why?
|
| Genetic Testing | 15 | 2025 | 1098 | 1.840 |
Why?
|
| Genetic Variation | 15 | 2025 | 1580 | 1.830 |
Why?
|
| Exome | 29 | 2025 | 1087 | 1.770 |
Why?
|
| Genetic Association Studies | 19 | 2025 | 852 | 1.710 |
Why?
|
| Abnormalities, Multiple | 12 | 2022 | 981 | 1.640 |
Why?
|
| Pedigree | 44 | 2025 | 1719 | 1.640 |
Why?
|
| Genome, Human | 9 | 2025 | 1331 | 1.470 |
Why?
|
| Genetic Predisposition to Disease | 24 | 2025 | 3350 | 1.460 |
Why?
|
| Microcephaly | 13 | 2025 | 351 | 1.400 |
Why?
|
| Mutation | 45 | 2025 | 6229 | 1.400 |
Why?
|
| Developmental Disabilities | 14 | 2025 | 756 | 1.240 |
Why?
|
| Scoliosis | 8 | 2025 | 143 | 1.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2026 | 1408 | 1.070 |
Why?
|
| DNA Copy Number Variations | 15 | 2024 | 1032 | 1.050 |
Why?
|
| Rare Diseases | 6 | 2024 | 209 | 1.040 |
Why?
|
| Mutation, Missense | 16 | 2025 | 935 | 1.000 |
Why?
|
| Urogenital Abnormalities | 5 | 2025 | 164 | 0.950 |
Why?
|
| Humans | 157 | 2026 | 132061 | 0.940 |
Why?
|
| Alleles | 19 | 2025 | 1686 | 0.920 |
Why?
|
| Dwarfism | 4 | 2021 | 103 | 0.910 |
Why?
|
| Pathology, Molecular | 3 | 2018 | 67 | 0.820 |
Why?
|
| Autistic Disorder | 6 | 2023 | 387 | 0.810 |
Why?
|
| Mosaicism | 4 | 2024 | 249 | 0.780 |
Why?
|
| Eye Abnormalities | 3 | 2022 | 104 | 0.770 |
Why?
|
| Patient Care | 1 | 2023 | 99 | 0.760 |
Why?
|
| Child, Preschool | 47 | 2026 | 14751 | 0.730 |
Why?
|
| Nervous System Malformations | 5 | 2023 | 131 | 0.710 |
Why?
|
| DNA-Binding Proteins | 14 | 2025 | 1977 | 0.700 |
Why?
|
| Metabolome | 2 | 2023 | 325 | 0.690 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2023 | 239 | 0.680 |
Why?
|
| Female | 87 | 2026 | 70710 | 0.670 |
Why?
|
| Nerve Tissue Proteins | 7 | 2024 | 1131 | 0.670 |
Why?
|
| Male | 83 | 2026 | 64920 | 0.650 |
Why?
|
| Homozygote | 13 | 2024 | 547 | 0.650 |
Why?
|
| Zebrafish | 9 | 2025 | 417 | 0.640 |
Why?
|
| Nuclear Proteins | 7 | 2024 | 1280 | 0.620 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 151 | 0.610 |
Why?
|
| Child | 54 | 2026 | 25789 | 0.610 |
Why?
|
| Genetic Heterogeneity | 2 | 2019 | 140 | 0.600 |
Why?
|
| Metabolomics | 1 | 2023 | 480 | 0.600 |
Why?
|
| Adolescent | 42 | 2026 | 20562 | 0.590 |
Why?
|
| Insulin Resistance | 1 | 2024 | 697 | 0.590 |
Why?
|
| Myelin P2 Protein | 1 | 2018 | 10 | 0.590 |
Why?
|
| Family | 7 | 2021 | 596 | 0.580 |
Why?
|
| Autism Spectrum Disorder | 5 | 2023 | 431 | 0.570 |
Why?
|
| Cataract | 3 | 2021 | 169 | 0.570 |
Why?
|
| Infant | 37 | 2025 | 13064 | 0.560 |
Why?
|
| 46, XX Disorders of Sex Development | 3 | 2023 | 26 | 0.550 |
Why?
|
| Cleft Lip | 2 | 2021 | 135 | 0.550 |
Why?
|
| Cleft Palate | 2 | 2021 | 154 | 0.550 |
Why?
|
| Epilepsy | 7 | 2021 | 889 | 0.540 |
Why?
|
| Transposases | 3 | 2019 | 44 | 0.530 |
Why?
|
| Databases, Genetic | 6 | 2024 | 501 | 0.530 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 137 | 0.530 |
Why?
|
| Membrane Proteins | 6 | 2024 | 1610 | 0.530 |
Why?
|
| Orthostatic Intolerance | 1 | 2016 | 6 | 0.510 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2024 | 861 | 0.500 |
Why?
|
| Failure to Thrive | 2 | 2021 | 91 | 0.500 |
Why?
|
| Alopecia | 2 | 2023 | 40 | 0.500 |
Why?
|
| Sequence Analysis, DNA | 8 | 2021 | 1799 | 0.500 |
Why?
|
| Brain Diseases | 3 | 2024 | 305 | 0.500 |
Why?
|
| Triploidy | 1 | 2015 | 2 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 946 | 0.490 |
Why?
|
| Zebrafish Proteins | 3 | 2025 | 129 | 0.480 |
Why?
|
| Congenital Disorders of Glycosylation | 3 | 2025 | 45 | 0.470 |
Why?
|
| Sequence Deletion | 3 | 2021 | 526 | 0.460 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2015 | 15 | 0.460 |
Why?
|
| Steroid Isomerases | 1 | 2015 | 8 | 0.460 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2026 | 23 | 0.460 |
Why?
|
| Nervous System Diseases | 4 | 2023 | 408 | 0.460 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 7 | 0.450 |
Why?
|
| Mouth Abnormalities | 1 | 2014 | 15 | 0.450 |
Why?
|
| Syndactyly | 1 | 2014 | 24 | 0.440 |
Why?
|
| Apnea | 1 | 2014 | 31 | 0.440 |
Why?
|
| Maxilla | 1 | 2014 | 39 | 0.440 |
Why?
|
| Fingers | 1 | 2014 | 67 | 0.440 |
Why?
|
| Vesico-Ureteral Reflux | 3 | 2025 | 85 | 0.440 |
Why?
|
| Congenital Abnormalities | 4 | 2023 | 303 | 0.430 |
Why?
|
| Mandible | 1 | 2014 | 80 | 0.430 |
Why?
|
| Base Sequence | 4 | 2015 | 2899 | 0.430 |
Why?
|
| Repressor Proteins | 4 | 2020 | 812 | 0.430 |
Why?
|
| Syndrome | 13 | 2023 | 1174 | 0.420 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2024 | 573 | 0.420 |
Why?
|
| T-Box Domain Proteins | 5 | 2022 | 122 | 0.410 |
Why?
|
| Knee Joint | 1 | 2014 | 173 | 0.400 |
Why?
|
| Urinary Tract | 2 | 2025 | 62 | 0.400 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2025 | 216 | 0.400 |
Why?
|
| Spastic Paraplegia, Hereditary | 2 | 2022 | 30 | 0.380 |
Why?
|
| Software | 4 | 2025 | 732 | 0.370 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 2 | 2022 | 12 | 0.360 |
Why?
|
| Animals | 34 | 2025 | 34881 | 0.360 |
Why?
|
| Cell Adhesion Molecules | 3 | 2023 | 233 | 0.360 |
Why?
|
| Lissencephaly | 2 | 2022 | 11 | 0.350 |
Why?
|
| Megalencephaly | 2 | 2022 | 60 | 0.350 |
Why?
|
| Homeodomain Proteins | 5 | 2021 | 575 | 0.350 |
Why?
|
| Carrier Proteins | 5 | 2024 | 1047 | 0.350 |
Why?
|
| Computational Biology | 5 | 2021 | 875 | 0.350 |
Why?
|
| Neoplasm Proteins | 4 | 2023 | 697 | 0.350 |
Why?
|
| Vesicular Transport Proteins | 3 | 2021 | 122 | 0.350 |
Why?
|
| Adult | 32 | 2025 | 31567 | 0.350 |
Why?
|
| Transcription Factors | 10 | 2024 | 2493 | 0.350 |
Why?
|
| Epilepsy, Generalized | 2 | 2022 | 65 | 0.340 |
Why?
|
| Arthrogryposis | 2 | 2022 | 39 | 0.340 |
Why?
|
| Heart Defects, Congenital | 4 | 2025 | 1866 | 0.330 |
Why?
|
| Movement Disorders | 2 | 2023 | 223 | 0.320 |
Why?
|
| Dystonia | 2 | 2022 | 171 | 0.320 |
Why?
|
| Facies | 6 | 2021 | 156 | 0.310 |
Why?
|
| Young Adult | 20 | 2025 | 9956 | 0.310 |
Why?
|
| Cohort Studies | 13 | 2021 | 5164 | 0.310 |
Why?
|
| Cerebellar Diseases | 2 | 2020 | 80 | 0.300 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 130 | 0.290 |
Why?
|
| Muscle Hypotonia | 5 | 2022 | 196 | 0.290 |
Why?
|
| Loss of Function Mutation | 4 | 2024 | 159 | 0.290 |
Why?
|
| Genetic Markers | 3 | 2019 | 617 | 0.290 |
Why?
|
| Mitochondrial Proteins | 3 | 2020 | 260 | 0.290 |
Why?
|
| Seizures | 7 | 2022 | 893 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2024 | 2849 | 0.290 |
Why?
|
| Hand Deformities, Congenital | 2 | 2021 | 94 | 0.280 |
Why?
|
| Anodontia | 2 | 2018 | 33 | 0.280 |
Why?
|
| Consanguinity | 5 | 2022 | 121 | 0.280 |
Why?
|
| RNA Helicases | 2 | 2019 | 69 | 0.280 |
Why?
|
| Gene Dosage | 2 | 2020 | 449 | 0.280 |
Why?
|
| Spine | 3 | 2024 | 147 | 0.280 |
Why?
|
| Mice | 20 | 2024 | 18507 | 0.270 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 70 | 0.270 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 253 | 0.270 |
Why?
|
| Mullerian Ducts | 3 | 2023 | 46 | 0.260 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 684 | 0.250 |
Why?
|
| Spasms, Infantile | 2 | 2019 | 175 | 0.250 |
Why?
|
| Infant, Newborn | 13 | 2025 | 8549 | 0.250 |
Why?
|
| Frameshift Mutation | 3 | 2023 | 200 | 0.250 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2026 | 27 | 0.240 |
Why?
|
| Haploinsufficiency | 3 | 2023 | 266 | 0.240 |
Why?
|
| Biological Ontologies | 1 | 2025 | 8 | 0.240 |
Why?
|
| DNA Transposable Elements | 1 | 2006 | 188 | 0.240 |
Why?
|
| Receptor, EphA4 | 1 | 2025 | 5 | 0.240 |
Why?
|
| Siblings | 2 | 2024 | 202 | 0.230 |
Why?
|
| Killer Cells, Natural | 2 | 2025 | 347 | 0.230 |
Why?
|
| Cytoskeletal Proteins | 2 | 2024 | 282 | 0.230 |
Why?
|
| Locomotion | 1 | 2025 | 61 | 0.230 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2025 | 8 | 0.230 |
Why?
|
| Transcription Factor AP-2 | 1 | 2025 | 22 | 0.230 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2023 | 257 | 0.230 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 441 | 0.230 |
Why?
|
| Spindle Apparatus | 1 | 2025 | 50 | 0.230 |
Why?
|
| Glucosyltransferases | 1 | 2025 | 50 | 0.230 |
Why?
|
| Central Nervous System | 2 | 2025 | 282 | 0.220 |
Why?
|
| Brain | 9 | 2024 | 3183 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2024 | 61 | 0.220 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2004 | 14 | 0.220 |
Why?
|
| Essential Hypertension | 1 | 2024 | 12 | 0.220 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2020 | 426 | 0.220 |
Why?
|
| Methyltransferases | 1 | 2025 | 81 | 0.210 |
Why?
|
| Receptors, Antigen | 1 | 2004 | 33 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2024 | 120 | 0.210 |
Why?
|
| Genes, Dominant | 2 | 2024 | 250 | 0.210 |
Why?
|
| Hyperparathyroidism | 1 | 2024 | 26 | 0.210 |
Why?
|
| Chromosome Aberrations | 2 | 2024 | 589 | 0.210 |
Why?
|
| Genotype | 8 | 2024 | 2697 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 4 | 2017 | 198 | 0.210 |
Why?
|
| Language | 1 | 2025 | 226 | 0.210 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 50 | 0.200 |
Why?
|
| Heterotaxy Syndrome | 1 | 2024 | 63 | 0.200 |
Why?
|
| DNA | 2 | 2022 | 1473 | 0.200 |
Why?
|
| Cell Polarity | 1 | 2024 | 124 | 0.200 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 180 | 0.200 |
Why?
|
| Alu Elements | 2 | 2021 | 67 | 0.200 |
Why?
|
| Biological Variation, Population | 2 | 2024 | 26 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 251 | 0.200 |
Why?
|
| Cerebellum | 3 | 2022 | 462 | 0.200 |
Why?
|
| Atrophy | 5 | 2022 | 252 | 0.200 |
Why?
|
| Autoimmunity | 1 | 2024 | 182 | 0.200 |
Why?
|
| GPI-Linked Proteins | 2 | 2021 | 107 | 0.200 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2022 | 14 | 0.190 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 133 | 0.190 |
Why?
|
| Heterozygote | 6 | 2021 | 713 | 0.190 |
Why?
|
| Myokymia | 1 | 2022 | 9 | 0.190 |
Why?
|
| RNA-Binding Proteins | 3 | 2022 | 604 | 0.190 |
Why?
|
| Information Dissemination | 2 | 2022 | 201 | 0.190 |
Why?
|
| Face | 3 | 2020 | 189 | 0.190 |
Why?
|
| Translocation, Genetic | 1 | 2024 | 356 | 0.190 |
Why?
|
| Polydactyly | 1 | 2022 | 18 | 0.190 |
Why?
|
| Contracture | 1 | 2022 | 27 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2023 | 146 | 0.190 |
Why?
|
| Apyrase | 1 | 2022 | 21 | 0.190 |
Why?
|
| Embryonic Development | 1 | 2024 | 221 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2026 | 17419 | 0.190 |
Why?
|
| Cerebellar Ataxia | 2 | 2019 | 69 | 0.190 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 23 | 0.190 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2022 | 40 | 0.190 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2019 | 178 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2020 | 136 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2025 | 490 | 0.180 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2022 | 72 | 0.180 |
Why?
|
| INDEL Mutation | 2 | 2019 | 92 | 0.180 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2021 | 28 | 0.180 |
Why?
|
| Language Development Disorders | 2 | 2020 | 179 | 0.180 |
Why?
|
| Fibroblasts | 3 | 2023 | 861 | 0.180 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 10 | 0.180 |
Why?
|
| Cation Transport Proteins | 1 | 2022 | 100 | 0.180 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 13 | 0.180 |
Why?
|
| Blepharophimosis | 1 | 2021 | 26 | 0.180 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2021 | 39 | 0.180 |
Why?
|
| Amino Acid Sequence | 6 | 2025 | 2669 | 0.180 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2021 | 9 | 0.180 |
Why?
|
| Micrognathism | 1 | 2021 | 67 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2021 | 236 | 0.180 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 409 | 0.180 |
Why?
|
| Wolffian Ducts | 1 | 2021 | 10 | 0.170 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 5 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 126 | 0.170 |
Why?
|
| Actins | 2 | 2021 | 334 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 540 | 0.170 |
Why?
|
| Wnt Proteins | 2 | 2021 | 224 | 0.170 |
Why?
|
| Iron Metabolism Disorders | 1 | 2020 | 12 | 0.170 |
Why?
|
| Genomic Instability | 1 | 2022 | 245 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 199 | 0.170 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 14 | 0.170 |
Why?
|
| DNA Repair | 1 | 2004 | 565 | 0.170 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 32 | 0.170 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 93 | 0.170 |
Why?
|
| Eczema | 1 | 2020 | 31 | 0.170 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3770 | 0.170 |
Why?
|
| Mediator Complex | 1 | 2021 | 63 | 0.170 |
Why?
|
| Symporters | 1 | 2021 | 77 | 0.170 |
Why?
|
| Drosophila melanogaster | 2 | 2024 | 844 | 0.170 |
Why?
|
| Spectrin | 1 | 2021 | 61 | 0.170 |
Why?
|
| Fibrillar Collagens | 1 | 2020 | 14 | 0.170 |
Why?
|
| Founder Effect | 1 | 2020 | 35 | 0.160 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 662 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 50 | 0.160 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 85 | 0.160 |
Why?
|
| Progeria | 1 | 2019 | 17 | 0.160 |
Why?
|
| Netrins | 1 | 2019 | 5 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 157 | 0.160 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 122 | 0.160 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 47 | 0.160 |
Why?
|
| Ribosomes | 1 | 2020 | 125 | 0.160 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 32 | 0.160 |
Why?
|
| Hip Dislocation | 1 | 2020 | 33 | 0.160 |
Why?
|
| Fibrillin-1 | 1 | 2019 | 60 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2020 | 93 | 0.160 |
Why?
|
| Lipodystrophy | 1 | 2019 | 33 | 0.160 |
Why?
|
| Liver Failure | 1 | 2020 | 91 | 0.160 |
Why?
|
| White Matter | 1 | 2022 | 214 | 0.160 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 450 | 0.160 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2020 | 73 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 624 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 256 | 0.150 |
Why?
|
| Growth Disorders | 1 | 2020 | 192 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2022 | 213 | 0.150 |
Why?
|
| Gene Frequency | 4 | 2024 | 749 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 45 | 0.150 |
Why?
|
| HEK293 Cells | 4 | 2025 | 799 | 0.150 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 168 | 0.150 |
Why?
|
| Tuberous Sclerosis | 1 | 2020 | 124 | 0.150 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 277 | 0.150 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 90 | 0.150 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 401 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 175 | 0.150 |
Why?
|
| Calcium Channels | 1 | 2019 | 163 | 0.140 |
Why?
|
| Microarray Analysis | 1 | 2019 | 236 | 0.140 |
Why?
|
| Chromosome Duplication | 2 | 2017 | 149 | 0.140 |
Why?
|
| Neural Conduction | 1 | 2018 | 85 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 35 | 0.140 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2018 | 33 | 0.140 |
Why?
|
| N-Terminal Acetyltransferase A | 1 | 2018 | 10 | 0.140 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2018 | 11 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2021 | 372 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2020 | 442 | 0.140 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2019 | 106 | 0.140 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 167 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2018 | 613 | 0.140 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2018 | 104 | 0.140 |
Why?
|
| Marfan Syndrome | 1 | 2019 | 148 | 0.140 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 126 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 152 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 36 | 0.140 |
Why?
|
| 46, XX Testicular Disorders of Sex Development | 1 | 2017 | 2 | 0.130 |
Why?
|
| Waardenburg Syndrome | 1 | 2017 | 10 | 0.130 |
Why?
|
| Arginine | 1 | 2019 | 343 | 0.130 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2017 | 22 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2019 | 301 | 0.130 |
Why?
|
| Hirschsprung Disease | 1 | 2017 | 38 | 0.130 |
Why?
|
| Neurons | 3 | 2022 | 1998 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2017 | 101 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2019 | 611 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 327 | 0.130 |
Why?
|
| Tilt-Table Test | 1 | 2016 | 9 | 0.130 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 109 | 0.130 |
Why?
|
| Arabs | 1 | 2016 | 30 | 0.130 |
Why?
|
| Autophagy | 1 | 2020 | 426 | 0.120 |
Why?
|
| Posture | 1 | 2016 | 144 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2024 | 578 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 3833 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2023 | 1067 | 0.120 |
Why?
|
| Chromosome Banding | 1 | 2015 | 140 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 444 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 473 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2015 | 45 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2020 | 1227 | 0.120 |
Why?
|
| Moyamoya Disease | 1 | 2015 | 42 | 0.110 |
Why?
|
| China | 3 | 2021 | 290 | 0.110 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 63 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2025 | 4703 | 0.110 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 1828 | 0.110 |
Why?
|
| Cell Line | 4 | 2023 | 2719 | 0.110 |
Why?
|
| Disease | 1 | 2016 | 127 | 0.110 |
Why?
|
| Glycosylation | 2 | 2025 | 126 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 768 | 0.110 |
Why?
|
| United States | 4 | 2025 | 11658 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4688 | 0.100 |
Why?
|
| Proteins | 1 | 2018 | 1036 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 379 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2391 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 758 | 0.090 |
Why?
|
| Genes, Recessive | 2 | 2024 | 193 | 0.090 |
Why?
|
| Kidney | 3 | 2025 | 1331 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 272 | 0.090 |
Why?
|
| Tubulin | 2 | 2022 | 72 | 0.090 |
Why?
|
| Mitochondria | 1 | 2016 | 747 | 0.090 |
Why?
|
| Quadriplegia | 2 | 2022 | 38 | 0.090 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 327 | 0.090 |
Why?
|
| Muscle Spasticity | 2 | 2022 | 61 | 0.080 |
Why?
|
| Age of Onset | 2 | 2024 | 621 | 0.080 |
Why?
|
| Penetrance | 2 | 2021 | 113 | 0.080 |
Why?
|
| Turkey | 2 | 2021 | 67 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 631 | 0.080 |
Why?
|
| DNA Helicases | 2 | 2023 | 239 | 0.080 |
Why?
|
| Democratic Republic of the Congo | 2 | 2020 | 16 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 951 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2022 | 456 | 0.070 |
Why?
|
| VDJ Recombinases | 1 | 2008 | 6 | 0.070 |
Why?
|
| Protein Conformation | 2 | 2021 | 827 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2022 | 3863 | 0.070 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 282 | 0.070 |
Why?
|
| Haplotypes | 2 | 2019 | 544 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2021 | 1116 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2020 | 615 | 0.060 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 2 | 2017 | 81 | 0.060 |
Why?
|
| Axons | 2 | 2022 | 390 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2006 | 128 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2020 | 416 | 0.060 |
Why?
|
| Radiography | 2 | 2019 | 819 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 3990 | 0.060 |
Why?
|
| Middle Aged | 6 | 2025 | 28964 | 0.060 |
Why?
|
| Gene Rearrangement | 1 | 2008 | 327 | 0.060 |
Why?
|
| Disease Management | 2 | 2021 | 561 | 0.060 |
Why?
|
| Pregnancy | 2 | 2018 | 7566 | 0.060 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2025 | 14 | 0.060 |
Why?
|
| Gestational Age | 2 | 2020 | 1224 | 0.060 |
Why?
|
| Centrosome | 1 | 2025 | 27 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2024 | 8 | 0.060 |
Why?
|
| Chromosome Segregation | 1 | 2025 | 73 | 0.060 |
Why?
|
| Demography | 1 | 2025 | 240 | 0.060 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2004 | 3 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 81 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 51 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2025 | 122 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2022 | 2674 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2024 | 47 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2024 | 110 | 0.050 |
Why?
|
| Chile | 1 | 2024 | 25 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 220 | 0.050 |
Why?
|
| Glycogen | 1 | 2023 | 53 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 14 | 0.050 |
Why?
|
| Protein Phosphatase 1 | 1 | 2023 | 54 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2024 | 129 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 142 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1952 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2023 | 40 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1347 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 27 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2024 | 254 | 0.050 |
Why?
|
| Spastin | 1 | 2022 | 8 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3761 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 20 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 94 | 0.050 |
Why?
|
| Arteries | 1 | 2024 | 222 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2004 | 601 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 38 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 205 | 0.050 |
Why?
|
| Minority Groups | 1 | 2024 | 249 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 16 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 81 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 43 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 89 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 26 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 255 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 77 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 291 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 1450 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 30 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 124 | 0.050 |
Why?
|
| Binding Sites | 1 | 2025 | 1256 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2024 | 456 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 84 | 0.050 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 27 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 96 | 0.050 |
Why?
|
| Zinc | 1 | 2022 | 124 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2022 | 57 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 123 | 0.050 |
Why?
|
| Calpain | 1 | 2021 | 43 | 0.040 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2021 | 10 | 0.040 |
Why?
|
| Finland | 1 | 2021 | 46 | 0.040 |
Why?
|
| Paternal Inheritance | 1 | 2021 | 11 | 0.040 |
Why?
|
| PAX8 Transcription Factor | 1 | 2021 | 14 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 131 | 0.040 |
Why?
|
| Talipes Cavus | 1 | 2020 | 2 | 0.040 |
Why?
|
| Genetic Pleiotropy | 1 | 2021 | 27 | 0.040 |
Why?
|
| Palate | 1 | 2020 | 16 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2021 | 25 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 38 | 0.040 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 243 | 0.040 |
Why?
|
| DNA Damage | 1 | 2004 | 511 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 263 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Glutamine | 1 | 2022 | 211 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 205 | 0.040 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2020 | 44 | 0.040 |
Why?
|
| Atrioventricular Block | 1 | 2021 | 47 | 0.040 |
Why?
|
| Protein Binding | 1 | 2025 | 1729 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 163 | 0.040 |
Why?
|
| Problem Behavior | 1 | 2021 | 39 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 177 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 149 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 445 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 144 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 763 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 65 | 0.040 |
Why?
|
| Bone Development | 1 | 2020 | 55 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 708 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 247 | 0.040 |
Why?
|
| Smad2 Protein | 1 | 2019 | 53 | 0.040 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2019 | 12 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2020 | 98 | 0.040 |
Why?
|
| Connectin | 1 | 2019 | 29 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 422 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 527 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 198 | 0.040 |
Why?
|
| Deafness | 1 | 2020 | 85 | 0.040 |
Why?
|
| Ankyrins | 1 | 2020 | 96 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 78 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2021 | 245 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 63 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 381 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 126 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 878 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 548 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2019 | 236 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 238 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 169 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 407 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 260 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 185 | 0.040 |
Why?
|
| Retina | 1 | 2022 | 491 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 365 | 0.040 |
Why?
|
| X Chromosome Inactivation | 1 | 2018 | 64 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 328 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2018 | 45 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 273 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 56 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2019 | 475 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 254 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2018 | 108 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 156 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 588 | 0.040 |
Why?
|
| Proteomics | 1 | 2022 | 596 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 21406 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2021 | 377 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2021 | 1608 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 654 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 2018 | 104 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2021 | 1253 | 0.030 |
Why?
|
| Workflow | 1 | 2018 | 135 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 824 | 0.030 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 127 | 0.030 |
Why?
|
| Epithelium | 1 | 2018 | 354 | 0.030 |
Why?
|
| Heart Atria | 1 | 2020 | 340 | 0.030 |
Why?
|
| SOXE Transcription Factors | 1 | 2017 | 15 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 338 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 246 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 360 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 370 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 100 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 480 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3611 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 2016 | 48 | 0.030 |
Why?
|
| Muscles | 1 | 2016 | 238 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 908 | 0.030 |
Why?
|
| Data Mining | 1 | 2016 | 60 | 0.030 |
Why?
|
| Cell Movement | 1 | 2019 | 889 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2019 | 771 | 0.030 |
Why?
|
| Apoptosis | 1 | 2022 | 1892 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 1014 | 0.030 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 57 | 0.030 |
Why?
|
| Echocardiography | 1 | 2021 | 1129 | 0.030 |
Why?
|
| Exons | 1 | 2018 | 805 | 0.030 |
Why?
|
| Hypogonadism | 1 | 2019 | 320 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 1033 | 0.030 |
Why?
|
| Amino Acids | 1 | 2017 | 626 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1558 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2015 | 296 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2658 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 551 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 359 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 373 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 1078 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 823 | 0.020 |
Why?
|
| Cognition | 1 | 2018 | 810 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 700 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 518 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1728 | 0.020 |
Why?
|
| Registries | 1 | 2018 | 1572 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4757 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3681 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2438 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 5009 | 0.020 |
Why?
|
| Esterification | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 93 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 158 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 138 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 381 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2008 | 140 | 0.020 |
Why?
|